Abstract
The pharmacokinetics and hepatic metabolism of [3H] ivermectin (IVM) and [3H]cyclosporin A (CSA) were investigated in a subpopulation of the CF-1 mouse stock naturally deficient in mdr1a p-glycoprotein (PGP). A survey of key drug-metabolizing activities in liver fractions from PGP-deficient (−/−) or wild-type (+/+) animals indicated the two subpopulations are not different in hepatic metabolic activity and capacity. Intravenous pharmacokinetics of CSA were identical between the two groups, and results from microsomal incubations indicated similar biotransformation of IVM and CSA in liver. Intestinal excretion of [3H]IVM and [3H]CSA was enhanced in PGP (+/+) animals. Absence of PGP resulted in higher blood concentrations of IVM after oral dosing, suggesting enhanced absorption of IVM in (−/−) mice. Concentrations of [3H]IVM and [3H]CSA were always greater in the brains of (−/−) mice compared with (+/+) mice after either i.v. or oral administration. In contrast, liver concentrations of either compound were not different between (+/+) and (−/−) animals after an i.v. dose. These results show the PGP (−/−) and (+/+) subpopulations of CF-1 mice are useful for studying the role of mdr1a PGP in systemic exposure and tissue disposition of PGP substrates in the absence of metabolism differences.
Footnotes
-
Send reprint requests to: Dr. Gloria Y. Kwei, Department of Drug Metabolism, Merck Research Laboratories, RY 80-D100, Rahway, NJ 07065. E-mail: kwei{at}merck.com
-
↵1 Current affiliation: Department of Safety Assessment, Merck Research Laboratories, West Point, PA.
- Abbreviations used are::
- PGP
- p-glycoprotein
- IVM
- ivermectin
- CSA
- cyclosporin A
- CYP
- cytochrome P-450
- AUC
- area under the (blood or plasma) concentration-time curve
- LC-MS
- liquid chromatography-mass spectrometry
- ELISA
- enzyme-linked immunosorbent assay
- Received July 15, 1998.
- Accepted January 28, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|